RWTH Aachen University

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Private

Established: 1870-01-01

Employees: 5K

Market Cap: -

Website: http://www.rwth-aachen.de

Clinical Trials

SAS in Patients With Bronchial Carcinoma

Not Applicable

Conditions: Sleep Apnea Syndrome
Bronchial Carcinoma

Interventions: Device: sleep apnea screening with ApneaLinkTM

First Posted Date: 2014-10-21

Last Posted Date: 2016-02-18

Lead Sponsor: RWTH Aachen University

Target Recruit Count: 100

Registration Number: NCT02270853

Locations: 🇩🇪
Medizinische Klinik I Uniklinik RWTH Aachen, Aachen, NRW, Germany
🇩🇪
Krankenhaus Merheim, Köln, NRW, Germany
🇩🇪
Florence-Nightingale Hospital, Düsseldorf, Germany

Effect of the Topical Application of Anaesthetics With EnkFiberoptic Atomizer During the Bronchoscopy

Phase 4

Conditions: Flexible Bronchoscopy

Interventions: Device: bronchoscope
Device: Enk Fiberoptic Atomizer

First Posted Date: 2014-10-13

Last Posted Date: 2016-02-18

Lead Sponsor: RWTH Aachen University

Target Recruit Count: 60

Registration Number: NCT02262442

Locations: 🇩🇪
Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, RWTH Aachen University Hospital, Aachen, North Rhine-Westphalia, Germany

Lung Volume Reduction Via Coils in Patients With COPD

Conditions: Chronic Obstructive Pulmonary Disease (COPD)

First Posted Date: 2014-09-22

Last Posted Date: 2015-11-20

Lead Sponsor: RWTH Aachen University

Target Recruit Count: 20

Registration Number: NCT02246569

Locations: 🇩🇪
RWTH Univerity Hospital MK1, Aachen, Germany

The Role of Biomarker in Serum, Cerebrospinal Fluid and Parenchyma in the Context of Aneurysmal Subarachnoid Hemorrhage.

Not Applicable

Conditions: Aneurysmal Subarachnoid Hemorrhage

Interventions: Procedure: Biomarker in serum, liquor, micro-dialysate
Procedure: Biomarker in serum and in liquor

First Posted Date: 2014-05-20

Last Posted Date: 2020-02-05

Lead Sponsor: RWTH Aachen University

Target Recruit Count: 310

Registration Number: NCT02142166

Locations: 🇩🇪
Department of Neurosurgery, University Hospital RWTH Aachen, Aachen, NRW, Germany

Influence on Erythropoetin-level by Xenon

Phase 3

Terminated

Conditions: Healthy Volunteers

Interventions: Drug: Xenon pro Anaesthesia 100 % (V/V)
Drug: Aer medicinalis Linde 100%

First Posted Date: 2014-05-02

Last Posted Date: 2015-03-31

Lead Sponsor: RWTH Aachen University

Target Recruit Count: 36

Registration Number: NCT02129400

Locations: 🇩🇪
University Hospital RWTH Aachen, Department for Anesthesia, Aachen, North-Rhine Westfalia, Germany

Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus

Phase 3

Terminated

Conditions: Diabetes Mellitus Type 2 (T2DM)
Vascular Inflammation
Plaque Morphology

Interventions: Drug: Placebo
Drug: Linagliptin

First Posted Date: 2014-03-04

Last Posted Date: 2017-04-12

Lead Sponsor: RWTH Aachen University

Target Recruit Count: 4

Registration Number: NCT02077309

Locations: 🇩🇪
Department of Internal Medicine I, University Hospital, Aachen, Germany
🇳🇱
Cardiovascular Research Institute Maastricht (CARIM), Maastricht, Netherlands

Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification

Phase 4

Completed

Conditions: Need of Long Term Oral Anticoagulation Therapy (OAT)
Existent Coronary or Valvular Calcification, or Both and Agatston Score > 50 in at Least One Location
Atrial Fibrillation or Pulmonary Embolism

Interventions: Drug: Rivaroxaban or Marcumar

First Posted Date: 2014-02-19

Last Posted Date: 2020-10-22

Lead Sponsor: RWTH Aachen University

Target Recruit Count: 192

Registration Number: NCT02066662

Locations: 🇩🇪
Hospital Coburg, Med. Clinic II for Internal Medicine and Cardiology, Coburg, Bavaria, Germany
🇩🇪
University Hospital Aachen, Department of Cardiology, Aachen, North Rhine Westphalia, Germany
🇩🇪
St.-Antonius-Hospital Eschweiler, Internal Medicine, Eschweiler, North Rhine Westphalia, Germany

Analysis of Myocardial Layer Specific Systolic and Diastolic Function During and After PCI

Not Applicable

Completed

Conditions: Myocardial Ischemia
Anginal Pain
Percutaneous Coronary Intervention

Interventions: Procedure: Percutaneous Coronary Intervention

First Posted Date: 2013-12-09

Last Posted Date: 2015-09-23

Lead Sponsor: RWTH Aachen University

Target Recruit Count: 19

Registration Number: NCT02004483

Locations: 🇩🇪
University Hospital Aachen, Aachen, NRW, Germany

Surrogate Markers for Sudden Cardiac Death in Patients With Diabetes Mellitus and End Stage Renal Disease

Not Applicable

Completed

Conditions: Diabetes Mellitus Type 2
End Stage Renal Disease

Interventions: Device: 12 lead Holter
Device: CGM Continuous Glucose Monitoring

First Posted Date: 2013-12-05

Last Posted Date: 2016-01-20

Lead Sponsor: RWTH Aachen University

Target Recruit Count: 60

Registration Number: NCT02001480

Locations: 🇩🇪
regioMed-Kliniken GmbH, Coburg, Bayern, Germany
🇩🇪
Department of Internal Medicine I University Hospital RWTH Aachen, Aachen, NRW, Germany
🇩🇪
University Hospital Würzburg, Würzburg, Bayern, Germany

Alcohol Detection Via Bioimpedance Mesurements

Completed

Conditions: Healthy

Interventions: Device: bioimpedance mesurements

First Posted Date: 2013-11-06

Last Posted Date: 2013-11-06

Lead Sponsor: RWTH Aachen University

Target Recruit Count: 12

Registration Number: NCT01977157

Locations: 🇩🇪
Department of Anaesthesiology, University Hospital Aachen, Aachen, North Rhine-Westphalia, Germany

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy